Disc Medicine (IRON) Share-based Compensation (2020 - 2026)

Disc Medicine (IRON) has 7 years of Share-based Compensation data on file, last reported at $11.9 million in Q1 2026.

• Share-based Compensation for Q1 2026 came in at $11.9 million, up 87.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $39.9 million (up 108.8% YoY), and the FY2025 annual result was $34.3 million, up 104.22% from the prior year.
• Share-based Compensation rose to $11.9 million in Q1 2026 per IRON's latest filing, from $10.0 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $11.9 million in Q1 2026 and troughed at $332000.0 in Q1 2022.
• A 5-year average of $4.2 million and a median of $4.1 million in 2024 frame the typical range for Share-based Compensation.
• The sharpest annual moves came in 2022 and 2024: Share-based Compensation plunged 86.65% in 2022, then jumped 296.29% in 2024.
• A 5-year view of Share-based Compensation shows it stood at $993000.0 in 2022, then surged by 94.06% to $1.9 million in 2023, then surged by 124.91% to $4.3 million in 2024, then surged by 131.73% to $10.0 million in 2025, then rose by 18.95% to $11.9 million in 2026.
• Business Quant data shows IRON's Share-based Compensation at $11.9 million in Q1 2026, $10.0 million in Q4 2025, and $9.5 million in Q3 2025.